Come up with a name for your new list and we'll add to it:
Clarimedix raised a round of funding on January 12, 2012. Investors include
Johnson & Johnson.
Clarimedix is a clinical-stage therapeutic device company developing a portfolio of safe, effective therapeutic products that will treat diseases triggered by underlying vascular dysfunction. The comp…